VIPS News 142.59 04/28/2014 06:14:29 Vipshop Holdings Limited

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vipshop Holdings Limited (VIPS) 142.59 $VIPS

Vipshop Filed 2013 Annual Report on Form 20-F
PR Newswire - Fri Apr 25, 8:51AM CDT
Vipshop Holdings Limited (NYSE: VIPS), China's leading online discount retailer for brands ("Vipshop" or the "Company" , today announced that the Company has filed its annual report on Form 20-F that includes its audited financial statements for three years ended December 31, 2013 with the Securities and Exchange Commission on April 25, 2014. The annual report is available on the Company's website at ir.vip.com. Holders of the Company's securities may request a hard copy of the Company's annual report free of charge according to the instructions provided on the Company's website.

Bull of the Day: Dangdang (DANG) - Bull of the Day
Kevin Cook - ZACKS - Thu Apr 24, 2:22AM CDT
Bull of the Day: Dangdang (DANG) - Bull of the Day

New Product Collections, Stock Price Movements, Company Updates, and Acquisitions - Analyst Notes on Target, Sysco, Vipshop, Pandora and Rite Aid
PR Newswire - Wed Apr 23, 8:33AM CDT
Today, Analysts Review released its analysts' notes regarding Target Corp. (NYSE: TGT), Sysco Corp (NYSE: SYS), Vipshop Holdings Limited (NYSE: VIPS), Pandora Media, Inc. (NYSE: P) and Rite Aid Corp. (NYSE: RAD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1515-100free.

Price Movements, Marketing Campaigns, Conference Calls, and Expanded Product Offerings - Analyst Notes on Vipshop, Kohl's, Dollar Tree, Sears Holdings, and Big Lots
PR Newswire - Mon Apr 21, 10:47AM CDT
Today, Analysts Review released its analysts' notes regarding Vipshop Holdings Limited (NYSE: VIPS), Kohl's Corp. (NYSE: KSS), Dollar Tree, Inc. (NASDAQ: DLTR), Sears Holdings Corporation (NASDAQ: SHLD) Big Lots Inc. (NYSE: BIG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1334-100free

Travelzoo (TZOO) Falls: Stock Goes Down 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 7:41AM CDT
Travelzoo has seen negative earnings surprise for the current quarter along with a significant decline in its share price for the past month

New Restaurant Openings, Financial Results Releases, Survey Results, and Stock Price Updates - Analyst Notes on MGM, Rite Aid, Viacom, Expedia and Vipshop
PR Newswire - Mon Apr 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MGM Resorts International (NYSE: MGM), Rite Aid Corp. (NYSE: RAD), Viacom, Inc. (NASDAQ: VIAB), Expedia Inc. (NASDAQ: EXPE) and Vipshop Holdings Limited (NYSE: VIPS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1073-100free.

Why Alcoa, Vipshop Holdings, and Nike All Rose
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Apr 08, 9:10PM CDT
After a sharp sell-off over the past two days, stocks rebounded today as investors bought the momentum names that had fallen off in recent weeks. As a result, the  Dow Jones Industrial Average   finished the day up just 10 points or 0.1%, while the ...

Why Vipshop Holdings Ltd. Jumped
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Apr 08, 7:10PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of  Vipshop Holdings  were moving higher once...

Nasdaq, China Names Lead Day; Alcoa Rises On Earnings
at Investor's Business Daily - Tue Apr 08, 4:29PM CDT
Major averages bounced higher in lower volume Tuesday. China growth names did the heavy lifting, fueling a day of outperformance for the Nasdaq. At the close, the Nasdaq rose 0.8% and the S&P 500 added 0.4%. The benchmark index fell below its 50-day...

Why 58.com, Barracuda Networks, and Vipshop Holdings Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Apr 08, 4:15PM CDT
This should be a big week for economic data, with minutes from the last Federal Open Market Committee meeting due tomorrow, weekly initial jobless claims and the Treasury budget to be released on Thursday, and the March Producer Price Index and...

Nasdaq Outperforms Early; China Growth Names Bounce
at Investor's Business Daily - Tue Apr 08, 10:56AM CDT
Major averages opened higher Tuesday and held gains about two hours into the session. The Nasdaq outperformed, rising 0.9%. The S&P 500 rose 0.4% and the Dow Jones industrial average added 0.2%. NYSE volume was tracking 11% higher than Monday. Nasdaq...

Will This Upgrade Help Vishop Holdings (VIPS) Stock Today?
at The Street - Tue Apr 08, 8:30AM CDT
Vishop Holdings (VIPS) shares were upgraded to 'outperform' from 'neutral' by Credit Suisse on Tuesday

Stock Futures Turn And Rise; HollySys, JinkoSolar Climb
at Investor's Business Daily - Tue Apr 08, 8:01AM CDT
Stock futures reversed out of early losses and edged higher ahead of Tuesday's open. Dow futures moved 19.1 points above fair market value. Nasdaq 100 futures traded up 8.3 points and S&P 500 futures were 1.6 points higher. The stock market today is...

Stocks Weaken In Late Trade; Questcor Pares Gains
at Investor's Business Daily - Mon Apr 07, 1:57PM CDT
Stocks continued to worsen in late trading Monday and were on pace for a third straight loss. The Nasdaq slumped 1.7% to a two-month low. The S&P 500 dropped 1.2%, putting it near its 50-day line. Meanwhile, the Dow Jones industrial average lost 1%....

Major Averages Face More Selling, Biotechs Rally Back
at Investor's Business Daily - Mon Apr 07, 11:01AM CDT
Stocks were under pressure and near session lows about two hours into Monday's session. Biotechs bucked the trend, rallying back after recent weakness. The Dow Jones industrial average lost 0.6%, while the Nasdaq and S&P 500 fell 0.5%. Nasdaq volume...

Critical Alerts For Rite Aid, AMD, Cemex, Vipshop, and China Life Insurance Released By InvestorsObserver
PR Newswire - Mon Apr 07, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for RAD, AMD, CX, VIPS, and LFC.

E-Commerce China Dangdang Inc Is on a Tear: Time to Take Gains?
Brian Stoffel, The Motley Fool - Motley Fool - Fri Apr 04, 5:30PM CDT
When it comes to investing, it'd be nice to find the next  Amazon.com  before it became...well...Amazon.com.  Don't you think? In  Dangdang , many beginning investors believe that they are, in fact, buying shares of China's iteration of Amazon for...

Ctrip.com to Return Shareholders Wealth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 11:30AM CDT
Ctrip.com International Ltd. recently approved a new share repurchase program.

Social Initiatives, Recognitions, Appointments, and Financial Results Schedules - Analyst Notes on United Continental, MGM Resorts, Vipshop, Pandora, and Time Warner Cable
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding United Continental Holdings, Inc. (NYSE: UAL), MGM Resorts International (NYSE: MGM), Vipshop Holdings Limited (NYSE: VIPS), Pandora Media, Inc. (NYSE: P), and Time Warner Cable Inc. (NYSE: TWC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading